TXMD

Therapeuticsmd Inc

• Dow Jones·07/06 20:32

  TherapeuticsMD Inc. Stock Slides 6.6%, Underperforms Market

• Dow Jones·06/29 20:34

  TherapeuticsMD Inc. Stock Advances 6.2%, Outperforms Market

• Dow Jones·06/18 20:32

  TherapeuticsMD Inc. Stock Slides 14.1%, Underperforms Market

• NASDAQ·06/15 02:02

  Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch

• Dow Jones·06/12 20:32

  TherapeuticsMD Inc. Stock Advances 20.9%, Outperforms Market

• Dow Jones·06/08 20:34

  TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

• TipRanks·05/12 20:47

  TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives

• Seeking Alpha·05/12 20:24

  Therapeutics MD reports Q1 results

• Reuters·05/12 20:13

  TherapeuticsMD swings to Q1 net income as license revenue rises

• PUBT·05/12 20:08

  TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000

• Reuters·05/12 20:05

  THERAPEUTICSMD INC - COMPANY CONTINUES TO EVALUATE STRATEGIC ALTERNATIVES INCLUDING ACQUISITION OR MERGER

• Dow Jones·04/27 20:33

  TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

• Dow Jones·04/06 20:32

  TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market

• TipRanks·04/01 15:39

  TherapeuticsMD Explains Brief Delay In Annual Filing

• Reuters·04/01 10:08

  TherapeuticsMD delays 2025 10-K after filing omits auditor report